Search

Search Constraints

You searched for: Author/Creator Razaghi, Emran

Search Results

2. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial. (March 2018)